Lundbeck
Based in Deerfield, Ill., Lundbeck US is an affiliate of H. Lundbeck A/S in Denmark, and focused solely
on accelerating therapies for brain disorders. The company is engaged in the research, development,
production, marketing and sale of innovative therapies that fulfill unmet medical needs among people
living with challenging and sometimes rare neurologic and psychiatric disorders. In its late-stage research
pipeline, the company has neurology compounds under investigation for Alzheimer’s disease and
epilepsy, in addition to therapies in development for mental health disorders. With a special commitment
to the lives of patients, families and caregivers, Lundbeck actively engages in hundreds of initiatives each
April 2015 11US15EBC0045
year that support our patient communities.